August 11, 2025: The FDA voices concern about sites that supply compounding ingredients - safemedicines.org
August 11, 2025: The FDA voices concern about sites that supply compounding ingredients - safemedicines.org — FDA update affecting Pharmaceutical Manufacturing (FDA/DEA).
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 4, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Pharmaceutical Manufacturing (FDA/DEA) (compounding outsourcing (503B)) should confirm how it applies to their specific situation before acting. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Pharmaceutical Manufacturing (FDA/DEA) move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears. Bookmark this briefing, share it with anyone on your team responsible for compliance, and check the source link above for the full official text before you make any decisions.
What changed
August 11, 2025: The FDA voices concern about sites that supply compounding ingredients - safemedicines.org
Who it affects
Pharmaceutical Manufacturing (FDA/DEA) (compounding outsourcing (503B))
What you must do
Read the update and assess whether your current setup needs to change.
Deadline
No fixed deadline was published, but changes like this are often enforced quickly — act promptly.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- DEA selects only cannabis foes to participate in marijuana rescheduling hearing - mjbizdaily.com
- PRESCRIPTION DRUGS—D.D.C.: IRA’s Drug Price Negotiation Program not unconstitutional, federal trial court holds - VitalLaw.com
- U.S. Seizes 300,000 Kilos of Meth Precursor Chemicals Sent from China Destined for Mexico’s Sinaloa Drug Cartel - Department of Justice (.gov)
- Prescription Drug Costs - Britannica
- Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations with government - pbs.org